v2.4.0.8
Condensed Consolidated Statements of Operations (USD $)
3 Months Ended 185 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2014
Revenue      
Sales     $ 2,994,931
Cost of sales     3,325,639
Gross Loss     (330,708)
Operating Expenses      
Depreciation     52,694
General, selling and administration 202,275 272,741 4,460,923
Market development     900,940
Product development costs 111,604 125,123 2,492,988
Professional fees 72,594 63,327 14,609,140
Total Operating Expenses 386,473 461,191 22,516,685
Operating Loss (386,473) (461,191) (22,847,393)
Other Expenses (Income)      
Interest 327,259 301,247 26,438,695
Write-down of equipment     36,623
Other expenses (income)   (17,548) 248,975
Total Other Expenses (327,259) 283,699 (26,724,293)
Net Loss $ (713,732) $ (744,890) $ (49,571,686)
Loss per share, basic and diluted (in Dollars per share) $ 0 $ 0 $ 0
Weighted average shares outstanding, - basic and diluted (in Shares) 239,477,909 237,455,687